This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

Q4 2025 Management View CEO David Rosa described 2025 as “a strong year for Intuitive, driven by multi-specialty da Vinci ...

Intuitive Surgical, Inc. has reported past fourth-quarter 2025 revenue of US$2.87 billion and full-year revenue of US$10.06 ...

Intuitive Surgical capped off the recovery in its shares with a strong Q4 2025 earnings release, lending support to the stock ...

Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and ...

Jan 22 (Reuters) - Intuitive Surgical on Thursday beat Wall Street estimates for fourth-quarter profit and revenue on growing ...